Rejin Kebudi
- Ophthalmology top 2%
- Ocular Oncology and Treatments 16
-
- Childhood Cancer Survivors' Quality of Life 20
- Oncology top 5%
- Genetics top 5%
- Glioma Diagnosis and Treatment 17
- Neurology top 5%
- Neuroblastoma Research and Treatments 27
-
- Sarcoma Diagnosis and Treatment 23
-
- Palliative Care and End-of-Life Issues 11
- Acute Lymphoblastic Leukemia research 10
-
- Testicular diseases and treatments 8
- Co-authors
- Ömer Görgünİnci̇ AyanEmin DarendelilerIan MagrathSidnei EpelmanMhamed HarifScott MacfarlaneEva Steliarova‐Foucher
- Journals
- Journal of Clinical Oncology (7 papers)SHILAP Revista de lepidopterología (2 papers)Blood (1 paper)
- Partner nations
- TürkiyeUnited StatesCanada
In The Last Decade
Rejin Kebudi
135 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 112
- Ophthalmology 221
- Pediatrics, Perinatology and Child Health 434
- Oncology 573
- Genetics 217
- Neurology 238
Countries citing papers authored by Rejin Kebudi
This map shows the geographic impact of Rejin Kebudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rejin Kebudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rejin Kebudi more than expected).
Fields of papers citing papers by Rejin Kebudi
This network shows the impact of papers produced by Rejin Kebudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rejin Kebudi. The network helps show where Rejin Kebudi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rejin Kebudi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 0 | |
| 9 | 2021 | 8 | |
| 10 | 2020 | 3 | |
| 11 | 2020 | 90 | |
| 12 | 2019 | 7 | |
| 13 | 2019 | 1 | |
| 14 | 2016 | 11 | |
| 15 | 2013 | 25 | |
| 16 | 2007 | 11 | |
| 17 | 2007 | 7 | |
| 18 | Terminal dönemde kanserli çocuk ve ailesine yaklaşım | 2006 | 3 |
| 19 | 1998 | 4 | |
| 20 | 1995 | 6 |
About Rejin Kebudi
Rejin Kebudi is a scholar working on Neurology, Genetics and Ophthalmology, having authored 148 papers that have together received 1.9k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (27 papers), Sarcoma Diagnosis and Treatment (23 papers), Childhood Cancer Survivors' Quality of Life (20 papers), Glioma Diagnosis and Treatment (17 papers), Ocular Oncology and Treatments (16 papers), Palliative Care and End-of-Life Issues (11 papers), Acute Lymphoblastic Leukemia research (10 papers) and Testicular diseases and treatments (8 papers). The work is most often cited by research in Ophthalmology (221 citations), Pediatrics, Perinatology and Child Health (434 citations) and Oncology (573 citations). Rejin Kebudi has collaborated with scholars based in Türkiye, United States and Canada. Frequent co-authors include Ömer Görgün, İnci̇ Ayan, Emin Darendeliler, Ian Magrath, Sidnei Epelman, Mhamed Harif, Scott Macfarlane, Eva Steliarova‐Foucher, Chi Kong Li and Fatma Betül Çakır. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.